Filing Flows

Filing Flows › Health Care › agilon health (AGL)

agilon health (AGL) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · agilon health (AGL) Q3 2026 earnings results →

Q3 2026 Revenue up 6% year over year to $1.5B · 2¢ of every $1 of revenue kept as net profit · operating margin 1.6%

agilon health made $1.5B in Q3 2026 (+6% Y/Y). Operating margin 1.6%, net earnings $34.9M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.

Revenue$1.5B
Year over year+6%
Operating margin1.6%
Net earnings$34.9M
Operating cash flow$49.9M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

agilon health Q3 2026 revenue breakdown: Sankey diagram of revenue, costs, profit and cash flow
agilon health Q3 2026 revenue breakdown — free to use with credit and a link (terms). Share on X
Embed this chart on your site

Free to use with the credit line. Click a box to select the code.

What changed this quarter

Revenue was $1.5B in Q3 2026, up 6% year over year and up 2% from the previous quarter.

Operating profit was $0.02B, a 1.6% margin (up 10.7 points year over year). Total costs fell 5% while revenue rose 6%. The fastest-growing cost line was General & admin (+19%). Net earnings were $0.03B. The effective tax rate was 10.3%. Non-operating items added $0.01B, 38% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $0.05B, 143% of net earnings. Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.01B. Capital expenditures of $3.3M left free cash flow of $0.05B.

Quarterly history

agilon health revenue by quarteragilon health revenue by quarter$1.5BQ1 2025$1.4BQ2 2025$1.4BQ3 2025$1.6BQ4 2025$1.4BQ1 2026$1.5BQ2 2026$1.5BQ3 2026
agilon health net earnings by quarteragilon health net earnings by quarter$12.1MQ1 2025−$104MQ2 2025−$110MQ3 2025−$189MQ4 2025$48.9MQ1 2026$18.0MQ2 2026$34.9MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 4, 2026$1.5B+6%1.6%$34.9M$49.9M
Q2 202610-QAug 5, 2026$1.5B+7%0.8%$18.0M−$57.3M
Q1 202610-QMay 6, 2026$1.4B-7%0.3%$48.9M$23.7M
Q4 202510-KFeb 25, 2026$1.6B+3%-12.3%−$189M−$20.5M
Q3 202510-QNov 4, 2025$1.4B-1%-9.1%−$110M−$18.2M
Q2 202510-QAug 4, 2025$1.4B-6%-8.3%−$104M−$35.1M
Q1 202510-QMay 6, 2025$1.5B-4%-1.4%$12.1M−$32.0M

Charts

agilon health: revenue growth, year over year and quarter over quarteragilon health: revenue growth, year over year and quarter over quarterY/YQ/Q-4%Q1 2025-6%-9%Q2 2025-1%+3%Q3 2025+3%+9%Q4 2025-7%-9%Q1 2026+7%+5%Q2 2026+6%+2%Q3 2026
Latest (Q3 2026): Y/Y +6%, Q/Q +2%.
agilon health: where the cash came from (+) and went (−), TTM to Q3 2026agilon health: where the cash came from (+) and went (−), TTM to Q3 2026Other investing$92.4MCash drawn (+) / kept (−)−$74.7MCapital spending−$12.8MOperating cash flow−$4.2MOther financing−$657K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
agilon health: profit against cash, quarter by quarteragilon health: profit against cash, quarter by quarterNet incomeOperating cash flow−$106M$16.4MQ4 2024$12.1M−$32.0MQ1 2025−$104M−$35.1MQ2 2025−$110M−$18.2MQ3 2025−$189M−$20.5MQ4 2025$48.9M$23.7MQ1 2026$18.0M−$57.3MQ2 2026$34.9M$49.9MQ3 2026
Latest (Q3 2026): Net income $34.9M, Operating cash flow $49.9M.
agilon health: diluted shares by fiscal yearagilon health: diluted shares by fiscal year323MFY2020373MFY2021408MFY2022409MFY2023411MFY2024414MFY2025
+28.0% since FY2020: more shares outstanding (issuance, stock pay).
agilon health: long-term debt falling due (FY2025)agilon health: long-term debt falling due (FY2025)$19.2M2026$15.8M2028
Cash $174M, short-term investments —, long-term debt $35.0M at 2025-12-31.
agilon health in its industry: growth against margin (10 companies, SIC 8090)agilon health in its industry: growth against margin (10 companies, SIC 8090)revenue growth, year over year →↑ operating marginmedian +5%median 9%DVAPGNYSHCVMDPARKCCELMRAIPFHOMGRXAGL (+6%, 2%)
Services-Misc Health & Allied Services, NEC; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About agilon health

Our business is transforming healthcare by empowering the primary care physicians (“PCP”) to be the agents for change in the communities they serve. We believe that PCPs, with their intimate patient-physician relationships, are best positioned to drive meaningful change in quality, cost and patient experience when provided with the right infrastructure and payment model. Through our combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, we believe we are poised to revolutionize healthcare for seniors across communities throughout the United States (“U.S.”). We believe our purpose-built model provides the necessary capabilities, capital and business model for existing physician groups to create a Medicare-centric, globally capitated line of business.

In its own words, from its 10-K, filed Feb 25, 2026.

agilon health against its Services-Misc Health & Allied Services, NEC peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +6% against the peers' median +5%. Operating margin: 1.6% against the peers' median 8.9%.

CompanyQuarterRevenueY/YOp. margin
AGL agilon healthQ3 2026$1.5B+6%1.6%
DVA DavitaQ3 2026$3.6B+5%14.0%
PGNY ProgynyQ3 2026$341M+9%10.3%
SHC Sotera HealthQ3 2026$325M+4%25.8%
VMD Viemed HealthcareQ3 2026$80.7M+12%8.6%
PARK Park Dental PartnersQ2 2026$66.2M+5%1.9%
CCEL Cryo Cell InternationalQ3 FY26$7.8M0%28.0%
MRAI MarpaiQ2 2026$4.2M-10%-82.4%
PFHO Pacific Health Care OrganizationQ3 2026$1.5M-5%8.9%

Source: agilon health 10-Q on SEC EDGAR · CIK 1831097 · Services-Misc Health & Allied Services, NEC

Guidance and outlook

agilon health: what its forward-looking statements are about (10-Q filed 2026-11-04)agilon health: what its forward-looking statements are about (10-Q filed 2026-11-04)Demand2Other2Costs1
5 statements; tone +0.00 (−1 all cautious, +1 all confident); 2 hedged.

13F: who owns AGL and who is buying

Largest holders of AGL (13F)Largest holders of AGL (13F)Clayton, Dubilier & Rice, LLC$429MMorgan Stanley$216MNorth Peak Capital Management, LLC$159MBlackRock$123MAQR Capital Management LLC$74.2MGoldman Sachs Group$73.6MVanguard Capital Management LLC$56.3MMarshall Wace, LLP$50.2MDurable Capital Partners LP$47.2MD. E. Shaw$41.8M
Funds' net buying of AGL by quarter (13F)Funds' net buying of AGL by quarter (13F)$02025-06−$1K2025-09$35K2025-12$113M2026-03$108M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on AGL

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare AGL with

中文版：agilon health（AGL）财报

Español · Français